SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

CHANNEL BY TOPICS


QUICK LINKS




Valdata Introduces Manufacturing Quality Control Solution

TMCnews


TMCnews Featured Article


February 28, 2012

Valdata Introduces Manufacturing Quality Control Solution

By Chris Freeburn, TMCnet Web Editor


Valdata Systems today unveiled its Manufacturing Execution System (MES) solution that permits customers to deliver quality and performance management in pre-weigh and batch manufacturing. The Fairfield, N.J.-based developer of chemical management solutions for the pharmaceutical industry noted that the MES system interfaces directly with host systems, inventory systems and electronic scales.


MES permits confirmation and validation of each step in the manufacturing process. If the software detects an error, it brings the manufacturing process to an immediate halt, preventing further production of defective products and limiting costs. Valdata states that this will help mitigate human error in product selection, over/under pouring, blending and data entry.

Part of Valdata’s Chemical Management System, a scale-integrated chemical inventory management software suite, MES features real-time tracking of inventory creation and consumption as well as computer-assisted ”prompt and police” steps to ensure correct weighing, formulation and processing. The software will integrate pre-weighing and/or commingling operations to enhance speed and reliability and automated enforcement of resource maintenance schedules. MES produces audit-ready tracking of container and lot level materials.

In a company statement, Valdata noted that recent quality problems experience by pharmaceutical firms including Novartis, suggest that enhanced quality control and performance management solutions require more general deployment throughout the pharmaceutical, and food and beverage industries. In January, Novartis recalled 1,645 lots of over-the-counter drugs due to quality control problems. The company had been alerted to the problems six months previously, but was unable to correct the problem before the recall was ordered. The recall cost Novartis an estimated $120 million. Valdata indicated that such situation could have been avoided with the application of quality management and monitoring solutions, which would have cost a fraction of the recall.

In fact, Forbes calculated that the recall could ultimately cost Novartis $560 million in lost sales over the next 12 months. Forbes reported that FDA inspectors had also written a “scathing” report stating that the company had failed “to respond to consumer complaints about bottles containing incorrect tablets, file reports with the FDA or send postage-paid materials to consumers so that further evidence could be examined.” The FDA rejected Novartis’ claims that the problems were beyond its control, noting that “plant personnel failed to properly investigate many complaints and could not present any evidence to justify its conclusion.




Edited by Tammy Wolf







Technology Marketing Corporation

2 Trap Falls Road Suite 106, Shelton, CT 06484 USA
Ph: +1-203-852-6800, 800-243-6002

General comments: [email protected].
Comments about this site: [email protected].

STAY CURRENT YOUR WAY

© 2024 Technology Marketing Corporation. All rights reserved | Privacy Policy